drugset / Trial / NCT00216008
Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation.
Phase 2
Terminated
42 enrolled
H. Lee Moffitt Cancer Center and Research Institute
Aventis Pharmaceuticals · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this research study is to find out the effectiveness of the experimental combination of Docetaxel, Cisplatin, and radiation therapy administered prior to the surgical removal of your esophageal cancer.
Timeline
- Start
- 2005-07
- Primary completion
- 2007-02
- Completion
- 2007-02
Outcome
Outcome not reported
Stopped: “IRB Closure”